The vaccine containing recombinant pertussis toxin induces early and long-lasting protection

Biologicals

Volumn 27, Issue 2, 1999, Pages 99-102

  Rappuoli, R ^a  

^a CHIRON VACCINES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN; PERTUSSIS VACCINE;

AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; ANTIGENICITY; DETOXIFICATION; DRUG EFFICACY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; PERTUSSIS; PRIORITY JOURNAL; SHORT SURVEY;

CHIRON;

EID: 0032741999     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1999.0189     Document Type: Article

References (7)

1. M Pizza A Covacci A Bartoloni Mutants of pertussis toxin suitable for vaccine development Science 246 1989 497 500
2. PH Ibsen The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies Vaccine 14 1996 359 368
3. KM Edwards BD Meade MD Decker Comparison of 13 acellular pertussis vaccines: overview and serologic response Pediatrics 96 1995 548 557
4. EL Hewlett Acellular pertussis trial Pediatrics 98 1996 800
5. D Greco S Salmaso P Mastrantonio A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis N Engl J Med 334 1996 341 348
6. D Greco S Salmaso P Mastrantonio A difference in relative efficacy of two DTaP vaccines in continued blinded observation of children following a clinical trial Pediatric Res 39 1996 173A
7. Greco, D, Salmaso, S, Mastrantonio, P, Additional vaccine efficacy estimates among acellular pertussis recipients in the Italian Pertussis Trial over prolonged follow-up. Presented at the 7th International Congress for Infectious Diseases, Hong Kong, June 10–13, 1996